Assessment and Recovery Centres (ARCs) - Pilot Locations

A Contract Addendum Notice
by NHS BLOOD AND TRANSPLANT

Source: Find a Tender
Type: Contract (Services)
Duration: not specified
Value: ___

Sector: HEALTH
Published: 26 Nov 2025
Delivery: not specified
Deadline: n/a

Related Terms

Location

Bristol

Geochart for 1 buyers and 0 suppliers

1 buyer

NHS Blood & Transplant Bristol

Description

An ARC is an Assessment and Recovery Centre facility that will bring together and implement ex situ machine perfusion techniques at the centre of a national network. Marginal organs will be retrieved and assessed for transplantation, extending their viability between donation and transplantation. In the future, organ function could be transformed and organs repaired.An ARC is proposed as a dedicated facility for organ perfusion techniques, utilising ex situ Machine Perfusion to undertake expert assessment, to de-risk transplantation and to better understand organ viability.NHS Blood and Transplant (NHSBT) are looking to establish contracts with suitably experienced NHS Transplant Centres who meet the mandatory requirements to become an ARC location during this pilot phase. Further locations may be added during the pilot phase.

Ammendments to Previous Notice

2. VI.3

This is a Provider Selection Regime (PSR) intention to confirmation of contract award notice. The awarding of this This contract is subject to has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight, 25th November 2025. This contract has not yet formally now been awarded; this notice serves as an intention to award under the PSR.The award decision-makers are the NHSBT ARC Project Board.The providers have been selected as formally awarded using the most suitable to obtain an effective range of locations during provider process.The contract will be valid until the pilot phase. Assessments have been made against mandatory criteria and 31st March 2027, with an option to extend to the key criteria. 30th November 2027. The lifetime value of the contract will be £1,560,000.